Safer MRI scans for infants? new contrast agent studied in toddlers
NCT ID NCT05590884
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a contrast agent called gadopiclenol in 36 infants under 2 years old who needed an MRI. The goal was to see how the drug behaves in their bodies and check for safety. The children received a single injection before their MRI, and researchers measured drug levels in the blood. This is an early step toward confirming the drug works well in very young children.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Gadopiclenol (a contrast agent used to brighten MRI images)
What this could lead to
If successful, this could confirm that gadopiclenol is safe and effective for use in very young children, improving MRI diagnosis in this age group.
What could go wrong
This is a small, early-phase study with only 36 children, so results may not apply to all infants. The drug is already approved for older children and adults, so major surprises are unlikely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnatti Childrens Hospital
Cincinnati, Ohio, 45229, United States
-
Instytut "Pomnik - Centrum Zdrowia Dziecka"
Warsaw, Poland
-
Instytut Centrum Zdrowia Matki Polki
Lodz, Poland
-
Kliniczny Szpital Wojewodzki Nr 2 im. Sw. Jadwigi Krolowej
Rzeszów, Poland
-
Medical University of South Carolina
Charleston, South Carolina, 29425-8908, United States
-
Országos Idegtudományi Intézet
Budapest, Hungary
-
Semmelweis Egyetem
Budapest, 1094, Hungary
-
Szpital Uniwersytecki nr 1 im. dr Antoniego Jurasza
Bydgoszcz, Poland
-
University of Debrecen Clinical Center Pediatric Department
Debrecen, Hungary
-
Uniwersytecki Szpital Dzieciecy
Lublin, Poland
-
Uniwersyteckie Centrum Kliniczne Warszawskiego
Warsaw, 02-091, Poland